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Introduction
The diffusion of gases brings the partial pressures of O2
and CO2 in blood and alveolar gas to an equilibrium at the
pulmonary blood-gas barrier. Alveolar PCO2 (PACO2) de-
pends on the balance between the amount of CO2 being
added by pulmonary blood and the amount being elimi-
nated by alveolar ventilation (V˙ A). In steady-state condi-
tions, CO2 output equals CO2 elimination, but during non-
steady-state conditions, phase issues and impaired tissue
CO2 clearance make CO2 output less predictable. Lung
heterogeneity creates regional differences in CO2 concen-
tration, and sequential emptying raises the alveolar plateau
and steepens the expired CO2 slope in expiratory capno-
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grams. Lung areas that are ventilated but not perfused
form part of the dead space. Alveolar dead space is po-
tentially large in pulmonary embolism, COPD, and all
forms of ARDS. When PEEP recruits collapsed lung units,
resulting in improved oxygenation, alveolar dead space
may decrease; however, when PEEP induces overdisten-
tion, alveolar dead space tends to increase. Measuring phys-
iologic dead space and alveolar ejection volume at admis-
sion or examining the trend during mechanical ventilation
might provide useful information on outcomes of critically
ill patients with ARDS.
Physiology of Carbon Dioxide
In normal conditions, CO2 is produced at the tissue level
during pyruvate oxidation as a result of aerobic metabo-
lism. The respiratory quotient shows the relationship be-
tween oxygen consumption (V˙ O2) and CO2 production(V˙ CO2): respiratory quotient  V˙ CO2/V˙ O2. In aerobic me-
tabolism, the respiratory quotient varies from 0.7 to 1 as a
function of the substrate being burned to produce energy.
Tissue PCO2 can also increase as a consequence of bicar-
bonate (HCO3) buffering of non-volatile acids (eg, lac-
tate) during tissue dysoxia,1,2 which can result in a respi-
ratory quotient of  13; lipogenesis can also produce a
respiratory quotient of  1 under aerobic conditions.4 Re-
gardless of its origin, CO2 has to leave the tissues, be
transported in blood, and be eliminated in the lungs, or
respiratory acidosis will develop.
CO2 transport in blood is complex. Tissue CO2 enters
capillary blood by simple diffusion resulting from a pres-
sure gradient. Thus, CO2 capillary pressure must remain
low for diffusion to continue. The 2 main mechanisms that
keep CO2 capillary pressure low are continuous capillary
flow and the low proportion of CO2 in solution. Blood
flow is the main determinant of tissue CO2 clearance, and
low flow increases the tissue PCO2-venous PCO2 differ-
ence.5,6 Various mechanisms maintain the proportion of
CO2 at low levels in solution in plasma (5%). Figure 1
shows the ways CO2 is transported. Once in blood, CO2
easily diffuses into red cells, where carbonic anhydrase
catalyzes the reaction with water to form carbonic acid,
which rapidly dissociates into HCO3 and H. Although
no carbonic anhydrases are present in plasma, it seems that
their presence in endothelial cells in pulmonary capillaries
enables some activity in plasma.7 Even though carbonic
acid is almost completely dissociated within red cells, the
accumulation of HCO3 and H would limit the amount
Fig. 1. Carbon dioxide transport in blood. CO2 produced during cell metabolism reaches the blood by simple diffusion driven by a partial
pressure gradient (higher in tissue, lower in blood). To allow CO2 to be cleared from tissues, this gradient must remain high. A series of
reactions keeps CO2 in solution low. Once in plasma, CO2 diffuses into red cells, where carbon anhydrase catalyzes the reaction with water
to produce carbonic acid (H2CO3), which subsequently dissociates into hydrogen (H
) and bicarbonate (HCO3
). Once again, the accu-
mulation of either H or HCO3
 would stop those reactions. However, protons are buffered by hemoglobin, and bicarbonate is exchanged
for extracellular chloride (Cl) by AE1 (Band 3). For more details, see text.
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of CO2 that blood can transport. However, H is buffered
by hemoglobin, and HCO3 is exchanged for Cl by Band
3 (anion exchanger 1 [AE1]), a membrane transport pro-
tein.8 As a consequence, bicarbonate is the main form of
CO2 transport, accounting for 95% of the total (mainly
in plasma).
In normal conditions, a negligible amount of CO2 is
transported as carbamino compounds, but this mechanism
can be markedly increased by inhibition of carbonic an-
hydrase (eg, by acetazolamide). CO2 binds mainly to
-amino groups at the ends of both - and -chains of
hemoglobin. Reduced hemoglobin is 3.5 times more ef-
fective than oxyhemoglobin as a CO2 carrier, so the re-
lease of oxygen at the tissue level increases the amount of
CO2 that hemoglobin can carry. This is the major compo-
nent of the Haldane effect. The other component is related
to H buffering: as hemoglobin releases oxygen, it be-
comes more basic, and its buffering capacity increases (see
Fig. 1).9
PACO2
PACO2 depends on the balance between the amount of
CO2 being added by pulmonary blood and the amount
eliminated by V˙ A. As the former is nearly continuous and
the latter is not, PACO2 varies during the ventilatory cycle(Fig. 2). PACO2 can be calculated (when inspired gas is free
from CO2) as CO2 output/V˙ A. V˙ A is the difference be-
tween tidal volume (VT) and dead-space volume (VD).
In steady-state conditions, CO2 output equals V˙ CO2; dur-
ing non-steady-state conditions, phase issues and impaired
tissue CO2 clearance make CO2 output less predictable.10
So, the equation can be re-written as: PACO2  V˙ CO2/V˙ A.
However, the magnitude of these variables varies in dif-
Fig. 2. Alveolar and airway CO2 during the ventilatory cycle: flow (upper graph) and mean alveolar and airway CO2 pressure scalars (lower
graph). Alveolar PCO2 (PACO2) is lower at end inspiration (as far as fresh air dilutes alveolar gas) and higher at end expiration (because blood
keeps releasing CO2 into the alveolus). PACO2 varies between alveoli: it is higher (A) in units with lower V˙A/Q˙ ratios (closer to mixed venous
PCO2) and lower (B) in units with higher V˙A/Q˙ ratios (closer to inspired PCO2). Airway CO2 is zero during inspiration (provided there is no
rebreathing, phase I of the capnogram). At the very beginning of expiration, CO2 remains zero as long as the gas comes purely from airway
dead space; it then increases progressively (phase II) when units start to empty (low time constant units first, high time constant units later).
Phase III is considered to represent alveolar gas, and the end of phase III (end-tidal PCO2 [PETCO2]) is used as a reference of mean alveolar
gas composition. Phase IV of the capnogram shows the sudden fall in PCO2 at the start of inspiration.
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ferent conditions, so corrections have to be made. V˙ A mea-
surements are expressed in body temperature and pressure
saturated with vapor (BTPS); V˙ CO2 is expressed in stan-
dard temperature and pressure dry (STPD) conditions;
and PACO2 measurements are expressed in body tempera-
ture and pressure dry (BTPD) conditions. So the above
equation must be used in the form: PACO2 (BTPD) 0.863
 V˙ CO2 (STPD)/V˙ A (BTPS), where 0.863 is a constant
that summarizes the corrections when V˙ CO2 and V˙ A mea-
surements are not provided in the same units.
Figure 3 (constructed from the adjusted equation) shows
the relationship between PACO2 and V˙ A for 2 different
V˙ CO2 values. This relationship is not linear: as PACO2 de-
creases, the increase in alveolar ventilation necessary to
reduce PACO2 increases.
PaCO2
When venous blood arrives at pulmonary capillaries, the
events illustrated in Figure 1 occur in the opposite order.
The fall in plasma PCO2 resulting from CO2 diffusion to the
alveolus results in CO2 being released from red cells, so
carbonic acid is converted to CO2 and H2O (carbonic an-
hydrase facilitates the reaction in both directions). The
drop in carbonic acid concentration leads to new formation
of H2CO3 from bicarbonate (from the cytoplasm and plasma
through Band 3) and protons (free and from hemoglobin).
CO2 is also free from carbamates. As the environment
becomes more basic, hemoglobin’s affinity for O2 increases
(Bohr effect).
PCO2 depends on CO2 concentration and the solubility co-
efficient in blood (SCB): PCO2  CO2  SCB. SCB varies
with temperature; at 37°C, it is 0.0308 mmol/L/mm Hg.11
At the pulmonary blood-gas barrier, the diffusion of
gases brings the PO2 and PCO2 of blood and alveolar gas to
an equilibrium, and when blood leaves the pulmonary cap-
illaries, it has the same PO2 and PCO2 as alveolar gas.
However, the blood that arrives at the left atrium has lower
PO2 and higher PCO2 because venous admixture and shunt(both physiologic and large) contaminates it with venous
blood. Likewise, exhaled gas has higher PO2 and lower
PCO2 than alveolar air because dead space pollutes it with
fresh air (Fig. 4).
The Concept of Dead Space
The concept of dead space accounts for those lung areas
that are ventilated but not perfused. The VD is the sum of
2 separate components of lung volume. One is the nose,
pharynx, and conduction airways, which do not contribute
to gas exchange and are often referred to as anatomic or
airway VD. The mean volume of the airway VD in adults
is 2.2 mL/kg,12 but the measured amount varies with body13
and neck/jaw12 position. The second component consists
of well-ventilated alveoli that receive minimum blood flow,
which is referred to as alveolar VD. In mechanical venti-
lation, the ventilator’s endotracheal tube, humidification
devices, and connectors add mechanical dead space, which
is considered part of the airway VD. Physiologic VD con-
sists of airway VD (mechanical and anatomic) and alveolar
VD; in mechanical ventilation, physiologic VD is usually
reported as the fraction of VT that does not participate in
gas exchange.14-16 Alveolar VD can result from an increase
in ventilation or a decrease in perfusion.10 The gas from
the alveolar VD behaves in parallel with the gas from
perfused alveoli, exiting the lungs at the same time as the
gas that effectively participates in gas exchange and dilut-
ing it; this is evident as the difference between PaCO2 and
end-tidal PCO2 (PETCO2).15,16 Beyond that, if the amount of
gas that reaches the exchange areas surpasses the areas’
capacity for perfusion (high V˙ A/Q˙ ratio), the excess gas
supplied by ventilation behaves like alveolar VD (func-
tional concept) (Fig. 5).
Measurement of Dead Space
In critical patients, correct measurement and calculation
of dead space provides valuable information about venti-
latory support and can also be a valuable diagnostic tool.
Nuckton et al17 demonstrated that a high physiologic VD/VT
was independently associated with an increased risk of
death in subjects diagnosed with ARDS. Changes in the
shape of the capnographic curve often indicate ventilatory
maldistribution, and several indices have been developed
Fig. 3. Nonlinear relationship between alveolar ventilation (V˙A) and
alveolar PCO2 (PACO2). The effects of changes in V˙A on PACO2 are far
more evident when basal V˙A is lower. Higher CO2 production
(V˙CO2)  200 mL/min, and lower V˙CO2  100 mL/min.
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to quantify maldistribution based on the geometrical anal-
ysis of the volumetric capnographic curve.18,19
Bohr
Bohr’s dead-space fraction (VD/VT) is calculated as
(PETCO2  PECO2)/PETCO2,15 where PECO2 is the mean ex-
pired PCO2 per breath, calculated as V˙ CO2/VT  (Pb 
PH2O), where Pb is barometric pressure and PH2O is water-
vapor pressure. It is simple but cumbersome to collect
PECO2 using a Douglas bag.
In certain situations, the Bohr equation’s use of PETCO2
can be problematic. In exercise, in acute hyperventilation,
or in presence of different alveolar time constants, PACO2
rises, often steeply, during expiration of alveolar gas, so
PETCO2 will depend on the duration of expiration. The dead
space so derived will not necessarily correspond to any of
the compartments of the dead space (instrumental, ana-
tomic, and alveolar).15,16,20
Enghoff
In 1931, Enghoff first demonstrated that the physiologic
dead space remained a fairly constant fraction of VT over
a wide range of VT. Physiologic VD/VT calculated from
the Enghoff modification of the Bohr equation15 uses PaCO2
with the assumption that PaCO2 is similar to PACO2: phys-
iologic VD/VT  (PaCO2  PECO2)/PaCO2.
Langley
Langley et al21 plotted the volume of CO2 elimination
per breath (V˙ eCO2) against the total expired volume to con-
trive an alternative method of calculating airway dead space.
This curvilinear graph is shown in Figure 6. A straight
best-fit line is extrapolated from the linear portion of the
graph, and the intercept of this line on the volume axis (X
axis) represents the dead space. This method correlates
with Fowler’s method for calculating airway VD (Fig. 7)
but has the added advantage that it does not rely on visual
interpretation to determine equal areas. Although several
factors can influence airway VD, in the critical care setting,
this volume remains relatively unchanged. Any changes in
measured physiologic VD/VT, without added equipment
dead space, are mostly a result of changes in alveolar VD.
It is clearly alveolar VD and its inherent interaction with
physiologic VD that are most important clinically.
Alveolar Ejection Volume
The advanced technology combination of airway flow
monitoring and mainstream capnography allows noninva-
Fig. 4. Model of relationship between ventilation and perfusion. Even when the gases at the blood-gas barrier are in complete equilibrium,
the composition of effluent (expiratory) gas differs from that of alveolar gas because effluent gas also contains gas from the alveolar dead
space (whose composition is that of the inspired gas). Similarly, the composition of arterial blood differs from that of capillary blood to the
extent that it is mixed with shunt blood (whose composition is that of mixed venous blood). This concept (the calculation of the difference
between expected composition and actual composition of the effluent media) is the basis for calculating both alveolar dead space and
shunt.
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sive breath-by-breath bedside calculation of V˙ eCO2 and the
ratio between alveolar ejection volume (VAE) and VT in-
dependent of ventilatory settings.22,23 VAE can be defined
as the fraction of VT with minimum VD contamination,
which may be inferred from the asymptote of the V˙ eCO2/VT
curve at end of expiration, whereby VD is equal to zero.
VAE is defined as the volume that characterizes this rela-
tionship, up to a 5% variation.23
Using the V˙ eCO2/VT curve, the fraction of volume flow
corresponding to alveolar gas exhalation can be calculated.
After a given volume has been exhaled, V˙ eCO2 progres-
sively increases to reach a total amount of V˙ eCO2 elimina-
tion in a single expiration. The increase in V˙ eCO2 is slightly
nonlinear because of alveolar inhomogeneity, in other
words, because of the presence of a certain amount of
alveolar gas contaminated by parallel VD. At the very end
of expiration, the gas exhaled comes only from the alveoli,
so it is pure alveolar gas. From this curve, the last 50
points of every cycle are back-extrapolated by least-squares
linear regression analysis. Assuming a fixed amount of VD
contamination (dead-space allowance), a point on the
V˙ eCO2/VT curve representing the beginning of the VAE is
obtained. The VAE is then obtained as the value of the
volume at the intersection between the V˙ eCO2/VT curve and
a straight line having the maximum value at end of expi-
ration and a slope equal to 0.95 (1 dead-space allow-
ance) times the calculated slope (Fig. 8). VAE is expressed
as a fraction of expired VT (VAE/VT).24
The VAE/VT ratio, an index of alveolar inhomogeneity,
correlates with the severity of lung injury and is not in-
Fig. 5. Alveolar dead space. A: An ideal unit (top) receives nearly equal amounts of ventilation and perfusion. B: When perfusion drops (and
ventilation is kept constant) (top), a fraction of the ventilation the unit is receiving (gray area) does not adequately participate in gas exchange
and behaves like parallel dead space (it leaves the lungs at the same time as alveolar ventilation [V˙A]). Bottom: histograms for ventilation
and perfusion for each situation. For clarity, only units with V˙A/Q˙  0 and lower than infinite are plotted (neither shunt nor serial dead space
is shown).
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fluenced by the set ventilatory pattern in acute lung injury
(ALI) or ARDS patients receiving mechanical ventilation.23
It follows that VAE/VT might have clinical applications in
lung disorders characterized by marked alveolar inhomo-
geneity, and indeed, measurement of VAE/VT at ICU ad-
mission and after 48 h of mechanical ventilation, together
with PaO2/FIO2, provided useful information on outcome in
critically ill patients with ALI or ARDS.25
Causes of Elevated Dead Space in Mechanically
Ventilated Patients
In patients with lung disease, VD can be large. Patients
with unevenly distributed ventilation and perfusion have
lung units in which the amount of ventilation is high rel-
ative to the amount of blood flow. The PCO2 in gas coming
from these units is lower than PaCO2. During expiration,
this gas mixes with gas coming from other lung areas in
which ventilation and perfusion are more closely matched,
diluting it so that expired PCO2, including PETCO2, can be
greatly different from PaCO2. In addition, the PCO2 of ex-
pired gas in patients with obstructive airway disease may
increase steeply during expiration because lung units that
empty late are poorly ventilated and contain gas with higher
CO2 concentrations. The effect of these late-emptying lung
units on expired PCO2 leads to a difference between PaCO2
and PETCO2 (Fig. 9).26
Pulmonary Embolism
Pulmonary embolism is most commonly due to blood
clots that travel through the venous system and lodge in
the pulmonary arterial tree. Spatial differences in blood
flow between respiratory units in the lung cause inefficient
gas exchange that is reflected as increased alveolar VD.
Occlusion of the pulmonary vasculature by an embolism
will result in a lack of CO2 flux to the alveoli in the
affected vascular distribution. The mechanical properties
may not be greatly affected, so these alveoli empty in
parallel with other respiratory units with similar time con-
stants. Because ventilation to the affected alveoli contin-
ues unabated, PCO2 in these alveoli decreases.27
In patients with sudden pulmonary vascular occlusion
due to pulmonary embolism, the resultant high V˙ /Q˙ mis-
match produces an increase in alveolar VD. This effect
enables volumetric capnography to be used as a diagnostic
tool at the bedside: in the context of a normal D-dimer
assay, a normal alveolar VD is highly reliable to rule out
pulmonary embolism.28 In patients with clinical suspicion
of pulmonary embolism and elevated D-dimer levels, cal-
culations derived from volumetric capnography such as
late dead-space fraction had a statistically better diagnostic
performance in suspected pulmonary embolism than the
traditional measurement of the P(a-ET)CO2 difference.28
Moreover, a normal physiologic VD/VT ratio makes pul-
monary embolism unlikely. Finally, volumetric capnogra-
phy is an excellent tool for monitoring thrombolytic effi-
cacy in patients with major pulmonary embolism.29
COPD
Mismatch of the distribution of ventilation and perfu-
sion within any single acinus results from spatial differ-
Fig. 7. Single-breath expiratory volumetric capnogram recorded in
a mechanically ventilated subject with COPD. PETCO2  end-tidal
PCO2; PECO2  mixed exhaled PCO2; PACO2  mean alveolar PCO2.
The solid lines indicate Fowler’s geometric method of equivalent
areas to calculate airway dead space. Airway dead space is mea-
sured from the beginning of expiration to the point where the
vertical line crosses the volume axis.
Fig. 6. Langley’s method for calculating airway dead-space vol-
ume (VDAW). Single-breath expiratory carbondioxide volume (V˙eCO2)
is plotted versus expired volume. Airway VD can be calculated
from the value obtained on the volume axis by back-extrapolation
from the first linear part of the V˙eCO2 versus volume curve (solid
line).
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ences in gas-flow distribution due to the differences in the
time constants of the respiratory units. PACO2 will vary
between respiratory units. In this situation, individual re-
spiratory units will empty sequentially at differing rates
and times dependent upon mechanical properties.
Pulmonary heterogeneity is, together with airway ob-
struction, a cardinal feature in the functional impairment
of COPD. Heterogeneity, mostly dependent on peripheral
involvement, increases with the severity of the disease;
therefore, volumetric capnography, a technique that basi-
cally explores regional distribution, can be a good tool to
determine the degree of functional involvement in patients
with COPD (see Fig. 9).30,31
Ventilation to regions with little or no blood flow (low
PACO2) affects pulmonary dead space. In patients with air-
flow obstruction, inhomogeneities in ventilation are re-
sponsible for the increase in VD. Shunt increases physio-
logic VD/VT as the mixed venous PCO2 from shunted blood
elevates the PaCO2, increasing physiologic VD/VT by the
fraction that PaCO2 exceeds the non-shunted pulmonary
capillary PCO2. The accuracy of physiologic VD/VT mea-
surement can be improved with a forced maximum exha-
lation, which reduces the P(a-ET)CO2 difference and physi-
ologic VD/VT because of more complete emptying of the
lungs, including peripheral alveoli that have a higher PCO2
level. Furthermore, maximum exhalation is generally pre-
ceded by maximum inhalation, resulting in a more even
distribution of gases within the alveoli.32,33
ARDS
Even mild forms of ARDS can severely alter respiratory
system mechanics.34,35 Most of these changes affect pe-
ripheral structures beyond the conducting airways: the in-
terstitium, alveolar spaces, and small airways. The main
consequence of peripheral lung injury is the development
of heterogeneities that affect the efficacy of respiratory gas
exchange and ventilatory distribution.34,35
Patients with ARDS have lung regions with low V˙ /Q˙
(and high PACO2) that usually coexist with others having
high V˙ /Q˙ (and low PACO2). The combination of these 2
conditions secondary to severe alveolar and vascular dam-
age results in increased pulmonary dead space. Moreover,
pulmonary dead space is increased by shock states, sys-
temic and pulmonary hypotension, and obstruction of pul-
monary vessels (massive pulmonary embolus and micro-
thrombosis). Dead space accounts for most of the increase
in the minute ventilation requirement and CO2 retention
that occur in severe ARDS,34 and the extent of lung inho-
mogeneities increased with the severity of ARDS and cor-
related with physiologic VD/VT.36 Mechanical ventilation
can substantially affect dead-space measurements, making
the variations in dead space more complex.37
Effects of Mechanical Ventilation on Dead Space
Mechanical ventilation makes it more difficult to un-
derstand variations in dead space at the bedside. On the
one hand, PEEP levels that recruit collapsed lung can re-
duce dead space, primarily by reducing intrapulmonary
shunt. On the other hand, overdistention promotes the de-
velopment of high V˙ /Q˙ regions with increased dead space.38
Therefore, a number of pulmonary and non-pulmonary
Fig. 8. Determination of alveolar ejection volume (VAE) in a healthy
subject. CO2 production (V˙CO2) is plotted as a function of expired
volume. From this curve, the last 50 points of every cycle are
back-extrapolated to represent the ideal lung behavior (straight
dashed line). Assuming a fixed amount of dead-space contami-
nation of 5% (red arrow), a straight line is plotted. Alveolar ejection
begins at the intersection between the sampled curve and the
straight line (black arrow). The volume between this point and end
of expiration is the VAE (shaded area).
Fig. 9. Three single-breath volumetric capnograms duringmechan-
ical ventilation in different scenarios: a subject with normal lungs
and 2 subjects with COPD with and without hypercapnia.
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factors might affect interpretation of dead-space variations
at the bedside.
Several studies in subjects with ARDS have shown that
hypoxemia is due to intrapulmonary shunt and regions
with very low V˙ /Q˙ .39 The multiple inert gas elimination
technique has also shown that patients with ARDS have a
large percentage of ventilation distributed to unperfused or
poorly perfused regions.39 Coffey et al38 found that oleic
acid-induced ARDS in dogs resulted in high VD/VT by
increasing shunt, inert gas dead space, and mid-range V˙ /Q˙
heterogeneity. Capnographic findings in patients with ALI
and ARDS are consistent with a high degree of ventilatory
maldistribution and poor ventilatory efficiency. Blanch and
co-workers25 reported that indices obtained from volumet-
ric capnography (Bohr’s VD/VT, phase 3 slope, and
VAE/VT) were markedly different in subjects with ALI and
ARDS than in control subjects. Bohr’s dead space and
phase 3 slope were higher in subjects with ALI than in
control subjects and higher in subjects with ARDS than in
both control and ALI subjects. Moreover, VAE/VT was
lower in subjects with ALI than in control subjects and
lower in subjects with ARDS than in both control and ALI
subjects.
Effect of VT
In recumbent, anesthetized, normal subjects, increasing
VT increases ventilatory efficiency. Studies in normal sub-
jects40 have shown that the convection-dependent non-
homogeneity of ventilation increases with relatively small
increases in VT, whereas non-homogeneity due to interac-
tion of convection and diffusion in the lung periphery
decreases. In an earlier study, Romero et al23 found that
VAE/VT changed significantly with volume in normal sub-
jects but not in subjects with ARDS. Even earlier, Paiva
et al41 showed that phase 3 slope decreases with increased
VT in normal subjects. It might seem reasonable to expect
that the increase in VT in subjects with ARDS would re-
cruit some alveolar units and thus improve the degree of
alveolar homogeneity to some extent.42 In fact, however,
recruited units would contribute to improvement in venti-
latory and mechanical efficiency only if they were strictly
normal and homogeneous. We can reasonably suppose
that the reason that VAE/VT does not increase with VT in
patients with ARDS is that recruited alveoli are mostly
diseased or that increased VT does not effectively recruit
new lung areas. Nowadays, VT is no longer used to in-
crease oxygenation because it causes injuries to lungs and
distant organs and poor outcome.34,35,43 Currently, the use
of a lung-protective ventilation strategy has also been ex-
tended to intermediate-risk and high-risk patients under-
going major surgical procedures because it was associated
with improved clinical outcomes and reduced health-care
utilization.44 This brings us to the current hypotheses that
elevated physiologic VD/VT and decreased VAE/VT are
signs of poor prognosis in ARDS, and their evolution dur-
ing treatment has an impact on final outcome.17,25,45,46
Effect of PEEP
Alveolar VD is significantly increased in ARDS and
does not vary with PEEP. However, when PEEP is admin-
istered to recruit collapsed lung units (resulting in im-
proved oxygenation), alveolar VD decreases unless over-
distention impairs alveolar perfusion. Breen and
Mazumdar47 found that the application of PEEP at
11 cm H2O to anesthetized, mechanically ventilated, open-
chested dogs increased physiologic VD, reduced V˙ eCO2,
and resulted in a poorly defined alveolar plateau. These
changes were mainly produced by a significant decrease in
cardiac output due to PEEP. In dogs with oleic acid-in-
duced ARDS, Coffey et al38 found that low PEEP reduced
physiologic VD/VT and intrapulmonary shunt. Conversely,
in the same animals, high PEEP increased the fraction of
ventilation delivered to areas with high V˙ /Q˙ , resulting in
increased physiologic VD/VT. When Tusman et al48 tested
the usefulness of alveolar VD for determining open-lung
PEEP in eight lung-lavaged pigs, they observed 2 inter-
esting physiologic effects. First, alveolar VD showed a
good correlation with PaO2 and with normally aerated and
non-aerated areas on computed tomography in all animals,
yielding a sensitivity of 0.89 and a specificity of 0.90 for
detecting lung collapse. However, PEEP also induced air-
way dilation and increased airway VD, thus affecting the
global effect of both on physiologic VD/VT. Finally, vari-
ations in dead space with the application of PEEP largely
depend on the type, degree, and stage of lung injury. Ex-
perimental ARDS induced by lung lavage potentially al-
lows for much greater recruitment at increasing increments
of PEEP49-51 than experimental ARDS models induced by
oleic acid injury or pneumonia, and comparisons with hu-
man ARDS remains speculative.
Blanch et al37 studied the relationship between the ef-
fects of PEEP on volumetric capnography and respiratory
system mechanics in subjects with normal lungs, with mod-
erate ALI, and with severe ARDS. Compared with control
subjects, subjects with ARDS had markedly decreased re-
spiratory system compliance (CRS) and increased total re-
spiratory system resistance. Increasing PEEP improved re-
spiratory mechanics in normal subjects and worsened lung
tissue resistance in subjects with respiratory failure; how-
ever, it did not affect volumetric capnography indices.
Other authors have corroborated these findings. Smith and
Fletcher52 found that PEEP did not modify CO2 elimina-
tion in subjects immediately after heart surgery. Beydon
et al53 studied the effect of PEEP on dead space in subjects
with ALI. They found a large physiologic VD/VT that
remained unchanged after PEEP was raised from 0 to
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15 cm H2O. In healthy anesthetized subjects, Maisch et al54
found that physiologic VD/VT and maximum CRS during a
decremental PEEP trial were lowest after a recruitment
maneuver. However, at the highest PEEP level during the
incremental PEEP trial when PaO2 and the increase in lung
volume induced by PEEP peaked, physiologic VD/VT de-
teriorated. Therefore, physiologic VD/VT and CRS are more
sensitive than PaO2 measurements for detecting lung over-
distention.19,40,54 Seminal studies on the effect of PEEP in
P(a-ET)CO2 difference showed similar results.55 Finally,
Fengmei et al56 evaluated the effect of PEEP titration fol-
lowing lung recruitment in subjects with ARDS on phys-
iologic VD/VT, arterial oxygenation, and CRS. Interestingly,
they found that optimal PEEP in these subjects was
12 cm H2O because, at this pressure, the highest CRS in
conjunction with the lowest physiologic VD/VT indicated a
maximum number of effectively expanded alveoli.
Variations in dead space and its partitions resulting from
PEEP largely depend on the type, degree, and stage of
lung injury. When PEEP results in global lung recruit-
ment, physiologic VD and alveolar VD decrease; when
PEEP results in lung overdistention, physiologic VD and
alveolar VD increase. Therefore, volumetric capnography
may be helpful to identify overdistention or better alveolar
gas diffusion in patients with ARDS.
Effect of Inspiratory Flow Waveforms and
End-Inspiratory Pause
Patients receiving pressure controlled inverse-ratio ven-
tilation had lower PaCO2 than those receiving the normal
inspiratory/expiratory ratio.57 Several studies have reported
that an exponentially decreasing inspiratory flow pattern
results in modest improvements in PaCO2 and dead space.
These phenomena are explained by an increased mean
distribution time for gas mixing, during which fresh gas
from the VT is present in the respiratory zone and is avail-
able for distribution in the lung periphery. The mean dis-
tribution time of inspired gas is the mean time during
which fractions of fresh gas are present in the respiratory
zone.19,58,59 It was recently proposed that setting the ven-
tilator to a pattern that enhances CO2 exchange can reduce
dead space and significantly increase CO2 elimination or
alternatively reduce VT. This option is especially interest-
ing when lung-protective ventilation results in hypercap-
nia. In particular, doubling the proportion of the inspira-
tory cycle from 20 to 40% (without creating auto-PEEP),59
increasing end-inspiratory pause up to 30% of the inspira-
tory cycle,58 or both60 markedly reduced PaCO2 and phys-
iologic VD/VT, allowing the use of protective ventilation
with low VT and enhancing lung protection.
Prone Position, PaCO2, and Dead Space
In patients with severe ARDS, prone positioning im-
proves survival.61 In the prone position, recruitment in
dorsal areas usually prevails over ventral derecruitment
because of the need for the lung and its confining chest
wall to conform to the same volume, with more homoge-
neous overall dorsal-to-ventral lung inflation and more
homogeneously distributed stress and strain than in the
supine position.62 Because the distribution of perfusion
remains nearly constant in both postures, prone position-
ing usually improves oxygenation and may be associated
with a decrease in PaCO2, an indirect reflection of the re-
duction in alveolar VD.63 Gattinoni et al64 also reported
improved prognosis in subjects in whom PaCO2 declined
after an initial prone position session. Charron et al65
showed that prone positioning induced a decrease in pla-
teau pressure, PaCO2, and alveolar VD/VT ratio and an in-
crease in PaO2/FIO2 and CRS; these changes peaked after
6–9 h. In fact, the respiratory response to prone position-
ing appeared more relevant when PaCO2 rather than PaO2/FIO2
was used. Protti et al66 investigated the gas exchange re-
sponse to prone positioning as a function of lung recruitabil-
ity, measured by computed tomography in a supine posi-
tion. Interestingly, changes in PaCO2, but not in oxygenation,
were associated with lung recruitability, which was in turn
associated with the severity of lung injury.
Prognostic Value of Dead-Space Measurement
Alterations in the pulmonary microcirculation due to
epithelial and endothelial lung cell injuries are character-
istic of most forms of ARDS. Consequently, pulmonary
ventilation and pulmonary and bronchial circulation are
compromised, and pulmonary artery pressure and dead
space increase. A high physiologic VD/VT fraction repre-
sents an impaired ability to excrete CO2 due to any kind of
V˙ /Q˙ .38 Traditionally, pulmonary hypertension in the course
of ARDS was considered a predictor of poor outcome.67
However, in the era of lung-protective ventilation using
low VT, elevated systolic pulmonary artery pressure early
in the course of ARDS is not necessarily predictive of poor
outcome, although a persistently large dead space in early
ARDS remains associated with increased mortality and
fewer ventilator-free days.68
Several studies have demonstrated this association.
Nuckton et al17 demonstrated that a high physiologic VD/VT
was independently associated with an increased risk of
death in subjects with ARDS. The mean physiologic VD/VT
was 0.58 early in the course of ARDS and was higher in
subjects who died than in those who survived. The dead
space was an independent risk factor for death (for every
0.05 increase in physiologic VD/VT, the odds of death
increased by 45%). Raurich et al45 studied mortality and
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dead-space fraction in 80 subjects with early-stage ARDS
and 49 subjects with intermediate-stage ARDS. In both
stages, the dead-space fraction was higher in subjects who
died than in those who survived and was independently
associated with a greater risk of death. Similar results were
reported by Lucangelo et al25 regarding measuring the
VAE/VT fraction at admission and after 48 h of mechanical
ventilation in subjects with ALI or ARDS and by Siddiki
et al69 regarding estimating physiologic VD/VT from the
calculation of V˙ CO2 using the Harris-Benedict equation.
Finally, Kallet et al70 tested the association between the
VD/VT fraction and mortality in subjects with ARDS di-
agnosed using the Berlin Definition34 who were enrolled
in a clinical trial incorporating lung-protective ventilation
and found that markedly elevated physiologic VD/VT
( 0.60) in early ARDS was associated with higher mor-
tality. In the clinical arena, measuring or estimating phys-
iologic VD/VT at bedside is an easy method to predict
outcome in ARDS and should be routinely incorporated to
monitor respiratory function in patients receiving mechan-
ical ventilation.71
Conclusions
Understanding the physiology of ventilation and mea-
suring the dead-space fraction at bedside in patients re-
ceiving mechanical ventilation may provide important
physiologic, clinical, and prognostic information. Further
studies are warranted to assess whether the continuous
measurement of different derived capnographic indices is
useful for risk identification and stratification and for track-
ing the effects of therapeutic interventions and mechanical
ventilation modes and settings in critically ill patients.
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